These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 2015573)

  • 21. [Therapeutic use of recombinant human erythropoietin in clinical practice].
    Scudla V
    Vnitr Lek; 1995 Mar; 41(3):210-4. PubMed ID: 7762184
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of recombinant human erythropoietin in the management of anemia associated with acquired immunodeficiency syndrome.
    Garnick MB; Abels R; Rudnick SA
    Contrib Nephrol; 1991; 88():282-92; discussion 293-4. PubMed ID: 2040191
    [No Abstract]   [Full Text] [Related]  

  • 23. The use of recombinant human erythropoietin (rHuEpo) in humans.
    Adamson JW; Eschbach JW
    Cancer Surv; 1990; 9(1):157-67. PubMed ID: 2276112
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Erythropoietin and the anaemia of chronic disease.
    Krantz SB
    Nephrol Dial Transplant; 1995; 10 Suppl 2():10-7. PubMed ID: 7644100
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of the anemia of multiple myeloma: the role of recombinant human erythropoietin.
    Barlogie B
    Semin Hematol; 1993 Oct; 30(4 Suppl 6):25-7. PubMed ID: 8153675
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transfusion and the use of blood products.
    King DJ
    Baillieres Clin Haematol; 1991 Apr; 4(2):545-69. PubMed ID: 1912669
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adverse effects of therapy for the correction of anemia in hemodialysis patients.
    Watson AJ
    Semin Nephrol; 1989 Mar; 9(1 Suppl 1):30-4. PubMed ID: 2648519
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reversing the anemia of renal failure.
    Hatch FE
    Hosp Pract (Off Ed); 1990 Feb; 25(2A):25-34. PubMed ID: 2105980
    [No Abstract]   [Full Text] [Related]  

  • 29. Recombinant erythropoietic growth factors as an alternative to erythrocyte transfusion for patients with "anemia of prematurity".
    Christensen RD
    Pediatrics; 1989 May; 83(5):793-6. PubMed ID: 2717299
    [No Abstract]   [Full Text] [Related]  

  • 30. [Treatment of renal anemia with recombinant human erythropoietin].
    Burghard R; Gordjani N; Leititis JU
    Monatsschr Kinderheilkd; 1989 Mar; 137(3):174-7. PubMed ID: 2716749
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of subcutaneous recombinant human erythropoietin (r-HuEPO) on anemia in cancer patients receiving platinum-based chemotherapy.
    Malik IA; Khan ZK; Hakimali A; Sabih M; Rehman G
    J Pak Med Assoc; 1998 May; 48(5):127-31. PubMed ID: 9813972
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Erythropoietin in the treatment of anemias].
    Spicka I; Klener P; Lachmanová J; Háber J
    Vnitr Lek; 1996 Mar; 42(3):197-9. PubMed ID: 8686210
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human recombinant erythropoietin: progress in clinical development.
    Kubiak W; Karwacki M; Mazur I
    Ann Univ Mariae Curie Sklodowska Med; 1994; 48 Suppl 3():39-50. PubMed ID: 8192531
    [No Abstract]   [Full Text] [Related]  

  • 34. Iron deficiency in patients with dialysis-associated anemia during erythropoietin replacement therapy: strategies for assessment and management.
    Van Wyck DB
    Semin Nephrol; 1989 Mar; 9(1 Suppl 2):21-4. PubMed ID: 2669082
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The future of r-HuEPO.
    Eschbach JW
    Nephrol Dial Transplant; 1995; 10 Suppl 2():96-109. PubMed ID: 7644114
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Non-cardiac benefits of human recombinant erythropoietin in end stage renal failure and anaemia.
    Morris KP; Sharp J; Watson S; Coulthard MG
    Arch Dis Child; 1993 Nov; 69(5):580-6. PubMed ID: 8257180
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [HuEPO treatment of anemia in preterm infants].
    Galligani L; Perona A
    Minerva Pediatr; 1994 Nov; 46(11):521-6. PubMed ID: 7870011
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Treatment of anemia in patients with renal failure using erythropoietin obtained by genetic recombination].
    Wiecek A; Kokot F; Grzeszczak W; Klin M
    Pol Tyg Lek; 1990 Sep 17-24; 45(38-39):782-6. PubMed ID: 2095546
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Experience of erythropoietin in anemia of end stage renal disease.
    Hussain R; Naqvi SA
    J Pak Med Assoc; 1991 Dec; 41(12):310-2. PubMed ID: 1770562
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The infectious risks of transfusions in the United States: a decision-analytic approach.
    Heymann SJ; Brewer TF
    Am J Infect Control; 1993 Aug; 21(4):174-82. PubMed ID: 8239047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.